Construction and validation of molecular subtype and signature of immune cell-related telomeric genes and prediction of prognosis and immunotherapy efficacy in ovarian cancer patients.

导出 LinkOut

翻译打印收藏纠错

作者： Lele,Ling ^[1] ; Bingrong,Li ^[1] ; Huijing,Wu ^[2] ; Kaiyong,Zhang ^[1] ; Siwen,Li ^[1] ; Boliang,Ke ^[3] ; Zhengyang,Zhu ^[4] ; Te,Liu ^[5] ; Peng,Liu ^[6] ; Bimeng,Zhang ^[1]

作者单位： Department of Acupuncture and Moxibustion, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[1] Department of Medical Affairs, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[2] School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China. ^[3] Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[4] Department of Neurosurgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[5] Shanghai Geriatric Institute of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China. ^[6]

关键词 MAP3K4 biomarkers immune cells ovarian cancer telomeric gene

主题词人类(Humans);女(雌)性(Female);端粒(Telomere);卵巢肿瘤(Ovarian Neoplasms);算法(Algorithms);肿瘤微环境(Tumor Microenvironment)

DOI 10.1002/jgm.3606

PMID 38282157

发布时间 2024-01-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交